Effect of fetal dexamethasone exposure on the development of adult insulin sensitivity in a rat model

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 21, Issue 9, 2008, Pages 623-628

  O'Brien, Karen ^a,c   Sekimoto, Hiroko ^b   Boney, Charlotte ^b   Malee, Maureen ^a  

^a WOMEN AND INFANTS HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

^c South Shore Hospital   (United States)

Author keywords

Dexamethasone; Fetal origins hypothesis; IRS 1; p85; Phosphatidylinositol 3 kinase; Sprague Dawley rats

Indexed keywords

DEXAMETHASONE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN P85; TAP WATER;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DELIVERY; FEMALE; GESTATIONAL AGE; IMMUNOPRECIPITATION; INSULIN SENSITIVITY; LIFESPAN; LIVER CELL; MALE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROGENY; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; SPRAGUE DAWLEY RAT; WESTERN BLOTTING;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; DEXAMETHASONE; FEMALE; GLUCOCORTICOIDS; GLUCOSE METABOLISM DISORDERS; INSULIN; INSULIN RECEPTOR SUBSTRATE PROTEINS; MALE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 53149094327     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050802213073     Document Type: Article

References (26)

1. Olsen J. Prenatal exposures and long term health effects. Epid Rev 2000;22:76-81.
2. Matthews S. Fetal glucocorticoid exposure and hypothalamo-pituitary- adrenal function after birth. Endocr Res 2004;30:827-836.
3. Dalziel S. Cardiovascular risk factors after antenatal exposure to betamethasone: 30-Year follow-up of a randomized controlled trial. Lancet 2005;365:1856-1862.
4. Barker DJ. Fetal origins of coronary heart disease. BMJ 1995;311:171-174.
5. Smith JT, Waddell BJ. Increased fetal glucocorticoid exposure delays puberty onset in postnatal life. Endocrinology 2000;141:2422-2488.
6. Nyrienda MJ, Lindsay RS, Kenyon CJ, Burchell A, Seckl JR. Glucocorticoid exposure in late gestation permanently programs rat hepatic phosphoenolpyruvate carboxykinase and glucocorticoid receptor expression and causes glucose intolerance in adult offspring. J Clin Invest 1998;101:2174-2181.
7. Jansson T, Lambert GW. Effect of intrauterine growth restriction on blood pressure, glucose intolerance and sympathetic nervous system activity in the rat at 3-4 months of age. J Hypertens 1999;17:1239-1248.
8. Moss TJ, Sloboda DM, Gurrin LC, Harding R, Challis JR, Newham JP. Programming effects in sheep of prenatal growth restriction and glucocorticoid exposure. Am J Physiol Regul Integr Com Physiol 2001;281:960-970.
9. Collison M, Campbell IW, Salt IP, Dominiczak AF, Connell JM, Lyall H, Gould GW. Sex hormones induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins. Diabetologia 2000;443:1374-1380.
10. LeRoith D, Werner H, Beitner-Johnson D, Roberts Jr CT. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995;16:143-163.
11. Rordorf-Nikolic, T, Van Horn DJ, Chen D, White M, Backer J. Regulation of phosphatidylinositol 3-kinase by tyrosyl phosphoproteins. J Biol Chem 1995;270:3662-3666.
12. White MF. The insulin signaling system and the IRS proteins. Diabetologia 1997;40:S2-7.
13. Boney C, Smith R, Gruppuso P. Modulation of insulin-like growth factor-I mitogenic signaling in 3T3-L1 preadipocyte differentiation. Endocrinology 1998;139:1638-1644.
14. Hales CN, Barker DP. Type 2 diabetes mellitus: The thrifty phenotype hypothesis. Diabetologia 1992;35:595-602.
15. Purdy LP, Metzger BE. Influences of intrauterine metabolic environment on adult disease: What may we infer from size at birth? Diabetologia 1996;39:1126-1130.
16. Shepherd PR, Withers DJ, Siddle K. Phosphoinositide 3-kinase: The key switch mechanism in insulin signaling. Biochem J 1998;333:471-490.
17. Ueki K, Fruman D, Yballe C, Fasshauer M, Klein J, Asano T, Cantley L, Kahn R. Positive and negative roles of p85α and p85β regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 2003;48:48 453-48 466.
18. Rajala R, Chan M, Tsiokas M, Leonidas R. Interaction of the retinal insulin receptor beta-subunit with the p85 subunit of phosphoinositide 3-kinase. Biochemistry 2004;43:5637-5650.
19. Bjornholm N, Kawano Y, Lehtihet M, Zierath J. Insulin receptor substrate-1 phosphorylation and phosphatidylinositol 3-kinase activity in skeletal muscle from NIDDM subjects after in vivo insulin stimulation. Diabetes 1997;46:524-527.
20. Maegawa H, Shigeta Y, Egawa K, Kobayashi M. Impaired autophosphorylation of insulin receptors from abdominal skeletal muscles in nonobese subjects with NIDDM. Diabetes 1991;40:815-819.
21. Rondinone C. Insulin receptor substrate is reduced and IRS-2 is the main docking protein for phosphatidylinositol 3-kinase in adipocytes from subjects with non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A 1997;94:4171-4175.
22. Cusi K, Maezono K, Osman A, Pendergrass M, Patti ME, Pratipanawatr T, Defronzo RA, Kahn, CR, Mandarino LJ. Insulin resistance differentially affects the PI 3-kinase and MAP kinase-mediated signaling in human muscle. J Clin Invest 2000;105:311-320.
23. Whitehead JP, Clark SF, Urso B, James DE. Signalling through the insulin receptor. Curr Opin Cell Biol 2000;12:222-228.
24. Pessin J, Saltiel A. Signaling pathways in insulin action: Molecular targets of insulin resistance. J Clin Invest 2000;106:165-170.
25. Wang Q. Protein kinase B/Akt participates in GLUT4 translocation by insulin in L6 myoblasts. Mol Cell Biol 1999;4008-4018.
26. Cong LN. Physiological role of Akt in insulin-stimulated translocation of GLUT4 in transfected rat adipose cells. Mol Endocrinol 1997;11:1881-1890.